• Home
  • Pharmaceuticals and Healthcare
End-Stage Renal Disease (ESRD) Drugs Market, Global Outlook and Forecast 2022-2028

End-Stage Renal Disease (ESRD) Drugs Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281435 | No. of Pages: 79 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022 
This report contains market size and forecasts of End-Stage Renal Disease (ESRD) Drugs in global, including the following market information:
Global End-Stage Renal Disease (ESRD) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global End-Stage Renal Disease (ESRD) Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five End-Stage Renal Disease (ESRD) Drugs companies in 2021 (%)
The global End-Stage Renal Disease (ESRD) Drugs market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Calcium Succinate Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of End-Stage Renal Disease (ESRD) Drugs include CTI BioPharma Corp, Merck & Co Inc, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the End-Stage Renal Disease (ESRD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End-Stage Renal Disease (ESRD) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Type, 2021 (%)
    Calcium Succinate
    Mk-3866
    Pacritinib
    Sanguinate
    Tesidolumab
    Others
Global End-Stage Renal Disease (ESRD) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Application, 2021 (%)
    Hospital
    Clinic
    ICU
    Others
Global End-Stage Renal Disease (ESRD) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End-Stage Renal Disease (ESRD) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies End-Stage Renal Disease (ESRD) Drugs revenues share in global market, 2021 (%)
Key companies End-Stage Renal Disease (ESRD) Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies End-Stage Renal Disease (ESRD) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    CTI BioPharma Corp
    Merck & Co Inc
    Novartis AG
    Prolong Pharmaceuticals LLC
    VESSL Therapeutics Ltd
1 Introduction to Research & Analysis Reports
    1.1 End-Stage Renal Disease (ESRD) Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global End-Stage Renal Disease (ESRD) Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global End-Stage Renal Disease (ESRD) Drugs Overall Market Size
    2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size: 2021 VS 2028
    2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global End-Stage Renal Disease (ESRD) Drugs Sales: 2017-2028
3 Company Landscape
    3.1 Top End-Stage Renal Disease (ESRD) Drugs Players in Global Market
    3.2 Top Global End-Stage Renal Disease (ESRD) Drugs Companies Ranked by Revenue
    3.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Companies
    3.4 Global End-Stage Renal Disease (ESRD) Drugs Sales by Companies
    3.5 Global End-Stage Renal Disease (ESRD) Drugs Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 End-Stage Renal Disease (ESRD) Drugs Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Players in Global Market
        3.8.1 List of Global Tier 1 End-Stage Renal Disease (ESRD) Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Market Size Markets, 2021 & 2028
        4.1.2 Calcium Succinate
        4.1.3 Mk-3866
        4.1.4 Pacritinib
        4.1.5 Sanguinate
        4.1.6 Tesidolumab
        4.1.7 Others
    4.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
        4.2.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2022
        4.2.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2023-2028
        4.2.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2017-2028
    4.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
        4.3.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2022
        4.3.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2023-2028
        4.3.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2017-2028
    4.4 By Type - Global End-Stage Renal Disease (ESRD) Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 ICU
        5.1.5 Others
    5.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
        5.2.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2022
        5.2.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2023-2028
        5.2.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2017-2028
    5.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
        5.3.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2022
        5.3.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2023-2028
        5.3.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2017-2028
    5.4 By Application - Global End-Stage Renal Disease (ESRD) Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Market Size, 2021 & 2028
    6.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
        6.2.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2022
        6.2.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2023-2028
        6.2.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2017-2028
    6.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
        6.3.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2022
        6.3.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2023-2028
        6.3.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2028
        6.4.2 By Country - North America End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2028
        6.4.3 US End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.4.4 Canada End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.4.5 Mexico End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2028
        6.5.2 By Country - Europe End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2028
        6.5.3 Germany End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.4 France End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.5 U.K. End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.6 Italy End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.7 Russia End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.8 Nordic Countries End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.5.9 Benelux End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2028
        6.6.2 By Region - Asia End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2028
        6.6.3 China End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.6.4 Japan End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.6.5 South Korea End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.6.6 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.6.7 India End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2028
        6.7.2 By Country - South America End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2028
        6.7.3 Brazil End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.7.4 Argentina End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales, 2017-2028
        6.8.3 Turkey End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.8.4 Israel End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.8.5 Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
        6.8.6 UAE End-Stage Renal Disease (ESRD) Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 CTI BioPharma Corp
        7.1.1 CTI BioPharma Corp Corporate Summary
        7.1.2 CTI BioPharma Corp Business Overview
        7.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
        7.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2017-2022)
        7.1.5 CTI BioPharma Corp Key News
    7.2 Merck & Co Inc
        7.2.1 Merck & Co Inc Corporate Summary
        7.2.2 Merck & Co Inc Business Overview
        7.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
        7.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2017-2022)
        7.2.5 Merck & Co Inc Key News
    7.3 Novartis AG
        7.3.1 Novartis AG Corporate Summary
        7.3.2 Novartis AG Business Overview
        7.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
        7.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2017-2022)
        7.3.5 Novartis AG Key News
    7.4 Prolong Pharmaceuticals LLC
        7.4.1 Prolong Pharmaceuticals LLC Corporate Summary
        7.4.2 Prolong Pharmaceuticals LLC Business Overview
        7.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
        7.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2017-2022)
        7.4.5 Prolong Pharmaceuticals LLC Key News
    7.5 VESSL Therapeutics Ltd
        7.5.1 VESSL Therapeutics Ltd Corporate Summary
        7.5.2 VESSL Therapeutics Ltd Business Overview
        7.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
        7.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2017-2022)
        7.5.5 VESSL Therapeutics Ltd Key News
8 Global End-Stage Renal Disease (ESRD) Drugs Production Capacity, Analysis
    8.1 Global End-Stage Renal Disease (ESRD) Drugs Production Capacity, 2017-2028
    8.2 End-Stage Renal Disease (ESRD) Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global End-Stage Renal Disease (ESRD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 End-Stage Renal Disease (ESRD) Drugs Supply Chain Analysis
    10.1 End-Stage Renal Disease (ESRD) Drugs Industry Value Chain
    10.2 End-Stage Renal Disease (ESRD) Drugs Upstream Market
    10.3 End-Stage Renal Disease (ESRD) Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 End-Stage Renal Disease (ESRD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com